Month: February 2021

The Future of Precision Medicine: Genomics and Digital Technology [Podcast]

Dr. James Lu co-founded population genomics company Helix in 2015, where he leads the research, regulatory policy and bioinformatics teams. He oversees the teams that develop and validate the science and technology behind Helix’s solution, including Helix’s next generation sequencing lab. Dr. Lu also works with Helix’s partners to design and execute population-scale genomic research initiatives.

Read More

GenXys Health Care Systems announces completion of oversubscribed seed round financing to enable continued market penetration with acclaimed precision prescribing software

GenXys, a health tech company focused on pharmacogenetic enhanced prescribing automation software, is pleased to announce that it has closed an oversubscribed seed round at $3 million. Led by Green Shield Canada, (GSC), with key investors including TELUS Ventures, Esplanade Ventures, Nimbus Synergies, and the Business Development Bank of Canada (BDC Capital).

Read More

New look for TreatGx questions

TreatGx has undergone some exciting changes to make it easier and faster than ever to generate personalized medication treatment options. As a result of this update, you may notice that some question categories may display as red and require you to…

Read More